Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.16 CAD | -3.03% | 0.00% | -8.57% |
Apr. 24 | Theralase Technologies Inc. announced that it has received CAD 0.7502 million in funding | CI |
Apr. 05 | Theralase Technologies Inc. Receives Canadian Cancer Vaccine Patent | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.57% | 27.97M | |
-37.75% | 12.3M | |
+19.38% | 994M | |
-32.70% | 212M | |
-35.85% | 74.33M |
- Stock Market
- Equities
- TLT Stock
- News Theralase Technologies Inc.
- Theralase Technologies Provides Update on Phase II Bladder Cancer Clinical Study